Our Mission
As a unique alliance of NGOs and healthcare companies, EURADIA’s mission is to improve the lives of people affected by diabetes both now and in the future, through advocacy of diabetes research in Europe at the highest political and societal levels of influence, by improving coordination of European diabetes research and by shaping the allocation of resources for such research through increased awareness.
What is EURADIA
Who we are: EURADIA is an alliance of non-governmental organisations (NGOs) and healthcare companies working for diabetes research. The NGOs include European academic and clinical researchers, healthcare professionals and patient groups.
What we do: We provide a platform for all those undertaking research to work together to benefit the wellbeing of people with diabetes, through advocacy for increased funding and improved coordination of diabetes research in Europe.
A Brief History of EURADIA
EURADIA began in 2003 as a collaboration of NGOs and healthcare companies with an interest in supporting and promoting diabetes research at European Level.
This successful collaboration has grown in number of stakeholders and has a Secretariat based in the UK.
EURADIA is an independent charity registered with the Charity Commission for England and Wales.
EURADIA in 2019
Come and find out about EURADIA and DIAMAP 2020. We will be at the following conferences and look forward to meeting you there: Diabetes UK Professional Conference 6-8 March, Liverpool,…
August 31, 2017
DIAMAP Project in 2019
The DIAMAP Road Map for Diabetes Research in Europe has been relaunched with a new interactive website www.diamap.eu. The website was demonstrated during research events in 2018. It is an interactive…
September 28, 2016
EURADIA Advocacy
Professor Andrew Boulton, EURADIA Chair, pictured here at the European Parliament with members of EURADIA and the European Coalition for Diabetes. Part of EURADIA's mission is advocate for increased resources…
September 27, 2016
Up front&free to read in March's @DiabetologiaJnl :Contemporary rates of renal disease progression are ⬇️ than expected but an important minority of people show rapid loss of eGFR clustered w/ other complications even when eGFR is not yet low https://t.co/L0XjPWoduM #editorspicks
Did you know since the 1960’s medicines and vaccines have helped increase life expectancy by more than ten years? Not much can claim to have had such an impact on people's lives #ValuingMedicine
Up front & free to read in Feb @DiabetologiaJnl : EASD and ADA publish 2019 update to consensus report on glucose lowering and #NewEvidence from CVOTs in type 2 diabetes. #T2D @EASDnews @AmDiabetesAssn @profmjdavies @uniofleicester https://t.co/JyazpN2LsN #editorspicks
Does pharmaceutical research need a revamp to improve patient treatments and outcomes? #ClinicalTrials #TreatmentOptimisation #DrugDevelopment @millar_sophie @ADHingorani @sile_lane @eortc @senseaboutsci New ESMH article 👉
Re-engineering pharmaceutical research for better patient outcomes - European Science-Media Hub
A so-called ‘productivity crisis’ has been ascribed to the pharmaceutical research and development industry. Despite increases in investme...
sciencemediahub.eu
Gotta love how @RenzaS (far left) and @janespeight (far right) frame the #IDF2019 tech panel, putting a strong focus on the person living with #diabetes - and of course #languagematters #doc #dedoc
Birmingham cancer research lab opens with bakery worker's £1.5m legacy
Lab opens with £1.5m from 'quiet bakery worker'
Michael Dubrowsky left his savings to the Birmingham Royal Orthopaedic Hospital where he was treated.
www.bbc.co.uk